Bridgewater Advisors Inc.
Source: SEC Form 13F · as of Mar 2026Bridgewater Advisors Inc. holds 27 biotech & pharma companies tracked by BioSniper, totaling $31.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$31.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 21,659 | $5.0M |
| LLYELI LILLY & Co | 4,051 | $4.1M |
| CAHCardinal Health Inc. | 18,547 | $3.4M |
| MRKMerck & Co., Inc. | 23,809 | $2.7M |
| ABBVAbbVie Inc. | 9,803 | $2.0M |
| PFEPFIZER INC | 67,640 | $1.8M |
| NVSNovartis AG | 10,249 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,637 | $1.4M |
| PMPhilip Morris International Inc | 6,661 | $1.2M |
| AZNASTRAZENECA PLC | 4,615 | $866K |
| ABTABBOTT LABORATORIES | 10,181 | $853K |
| AMGNAMGEN INC | 2,545 | $852K |
| GILDGILEAD SCIENCES, INC. | 5,999 | $798K |
| NVONovo Nordisk A/S | 11,007 | $518K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,109 | $503K |
| RDYDR REDDYS LABORATORIES LTD | 37,404 | $486K |
| MCKMcKesson Corporation | 596 | $434K |
| BMYBRISTOL MYERS SQUIBB CO | 7,288 | $402K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,638 | $287K |
| ARGXARGENX SE | 334 | $268K |
| SNYSanofi | 6,228 | $264K |
| BIIBBIOGEN INC. | 1,223 | $243K |
| REGNREGENERON PHARMACEUTICALS, INC. | 319 | $225K |
| TEVATeva Pharmaceutical Industries Limited | 6,012 | $218K |
| ELVElevance Health Inc. | 528 | $211K |
| GMOptec International, Inc. | 2,753 | $207K |
| LXRXLEXICON PHARMACEUTICALS, INC. | 82,209 | $201K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.